Normal human bone marrow stromal cells (BMSC) were isolated from Dexter-type long-term cultures according to their capacity to adhere to plastic and to their lack of hematopoietic antigens. The BMSC displayed a homogeneous appearance and a myofibroblastic phenotype in culture. The stromal cells (SC) were shown to support the proliferation of purified CD34+ hematopoietic progenitors and permitted us to maintain myeloid cells for several weeks in culture. In addition, the BMSC induced the proliferation of purified CDlO+sp-fetal BM B-cell precursors (BCP). The capacity of the BMSC to induce the proliferation of early myeloid cells was shared by several other human fibroblastic-like cell types. In contrast, the BMSC were far superior to other adherent cells for induction of BCP proliferation. This capacity was largely mediated by endogenously pro-
ELLS FROM DIFFERENT hematopoietic lineages
C proliferate and differentiate in the bone marrow (BM), in close association with accessory cells of nonhematopoietic and hematopoietic origin, which constitute the medullary microenvironment.
The importance of such interactions has been shown in vivo by the hematopoietic disorders observed in Sl/Sld mice as a result of a defect in the BM microenvironment, affecting the production of the c-kit ligand.' Evidence for the crucial role of accessory cells in the formation of a microenvironment supporting hematopoiesis has also been obtained from studies of long-term BM cultures, in which proliferation and renewal of primitive hematopoietic cells is strictly dependent on the development of an adherent layer.'s3 Such long-term cultures have been instrumental for the understanding of murine myelopoiesis' and have been successfully modified to permit long-lasting murine B-lymphopoie~is. 4 .~ In humans, production of myeloid progenitors can be maintained several weeks in long-term BM culture~,~.' and progress has recently been made in establishing human B-lymphoid precursor cultures on adherent Adherent layers in long-term BM cultures are predominantly composed of nonhematopoietic elements refered to as stromal cells (SC) ." However, the adherent layers also include cells of hematopoietic rigi in.^,"-'^ In the mouse, the 
MATERIALS AND METHODS

Isolation and Culture of BMSC
Human femur fragments obtained after informed consent of adult donors undergoing orthopedic hip surgery were dilacerated to yield a BM cell suspension. Cells were seeded in a minimal essential medium (aMEM; GIBCO, Grand Island, NY) supplemented with 12.5% vol/vol horse serum (Flow Laboratories, Irvine, UK), 12.5% vol/vol fetal calf serum (FCS; Flow Laboratories), 0.4 mg/mL glutamine, mol/L hydrocortisone (Sigma, St Louis, MO), mol/ L a-monothioglycerol, and fungizone ( 5 pg/mL), hereafter refered to as complete aMEM medium, and placed in a fully humidified atmosphere at 37°C and 5% CO,, as previously described." After 24 hours of incubation, nonadherent cells were removed from the cultures, and plates were flushed three times with complete aMEM. Such early removal of nonadherent cells has previously been shown to abrogate intrinsic hematopoiesis in long-term BM cultures.23 Adherent cells were further cultured for 7 to 10 days in complete aMEM medium and were subsequently incubated in a 0.05% wt/vol trypsin/EDTA solution at 37°C until cells were completely detached. Cells were then washed free of trypsin and allowed to reexpress surface-membrane molecules (2-hour incubation at 37°C in RPMl 1640 medium [GIBCO] supplemented with 20% vol/vol FCS, with periodic agitation to prevent cell adhesion). Cells of hematopoietic origin were removed from the stromal population by exposure to a cocktail of monoclonal antibodies (MoAbs; anti-CD45, GAP 8.3),24 antLCD14 (Becton Dickinson, Mountain View, CA), anti-CD20, antLCD33 (Coulter Immunology, Hialeah, FL), anti-CD 19, anti-CD2, and anti-CD3 (all from Immunotech, Marseille, France), followed by depletion of reactive cells using immunomagnetic Dynabeads M-450 coated with an antimouse Ig (10 beads/cell; Dynal, Oslo, Norway).
After isolation, BMSC were plated in culture dishes in complete aMEM medium at the same cell concentration as before trypsinization and were subsequently allowed to reach confluence.
Phenotypic Analysis of BMSC
Fluorescence-activated cell sorter (FACSJ-analysis. Confluent BMSC were washed three times in phosphate-buffered saline without Ca2+ or Mg2+ (GIBCO) and covered with 0.05% wt/vol trypsin/ EDTA as described above. After detachment, cells were washed three times and incubated for 2 hours at 37°C in RPMI 1640 supplemented with 20% vol/vol FCS.
Cell-surface membrane immunofluorescence was performed according to standard techniques, using murine MoAbs disclosed by fluorescein isothiocyanate (FITC)-conjugated sheep F(ab'), antimouse Ig (Bioart, Meudon, France). Antibodies used are summarized in Table 1 . For all MoAbs, negative controls were provided by monoclonal mouse Ig of the same isotype but of unrelated specificity. Fluorescence was analyzed on a FACScan flow cytometer (Becton Dickinson). Data were subsequently processed using the Lysis program (Becton Dickinson).
In situ analysis. BMSC were cultured on plastic Lab-Tek chambers (Miles, Naperville, IL) to allow in situ immunofluorescence staining of the confluent cells, as previously described:' using the MoAbs listed in Table 1 .
Isolation of B-Cell Precursors (BCP)
Human fetal femurs were obtained according to institutional guidelines after spontaneous abortions occumng between 18 and 24 weeks of pregnancy. Fetal BM was collected as previously described.26 Cells expressing CD 10 antigen were isolated from the mononuclear fractions by immune panning with antLCD10 MoAb (ALB-1 ; Immunotech), using a procedure described elsewhere.26 Subsequent purity of the CD IO+ cells was greater than 98% as evaluated by flow cytometric analysis after staining with anti-CD10. All CDIO+ cells expressed the B-lineage CD 19 antigen, as previously reported?6 Sp' cells were further removed from the CD10+ fraction by immunomagnetic bead depletion (20 beads/cells) after labeling with an anti-p-chain MoAb (Immunotech). This step was necessary to obtain a pure population of BCP, because CDlO is retained on surface IgM+ (sIgM+) cells in fetal ~ntogeny.~'
Isolation of CD34+ Cells
Lightdensity mononuclear cells were isolated from umbilical cord blood collected during normal term deliveries or from BM obtained by iliac crest aspiration from adult donors free of hematologic disease. All procedures were performed according to institutional guidelines. Adherent cells were depleted by overnight incubation at 37OC in RPMI 1640 medium supplemented with I% wt/vol tissue culture grade bovine serum albumin (Boehringer, Mannheim, Germany). Cells bearing CD34 antigen were subsequently isolated from the nonadherent mononuclear fraction through positive selection by immune panning using anti-CD34 MoAb (Immu- For personal use only. on October 26, 2017. by guest www.bloodjournal.org From 133; Immunotech), as previously described in When the punty of the isolated cells was below 95%, a second purification step was performed using immunomagnetic bead depletion of contaminant mature cells of hematopoietic origin." The cells used in the present study were 95% to 99% CD34+, as judged by FACS-analysis with anti-CD34 MoAb. Of importance, CD34' cells isolated from cord blood do not include detectable BCP, as indicated by lack of CD 19 antigen expression."
Short-Term Proliferation of Hematopoietic Cells on Adherent Layers
A total of IO4 CDlO'sp-fetal BM BCP or 2 X IO' cord blood CD34' cells were seeded in 96-well flat-bottomed microtiter plates (Becton Dickinson) containing confluent BMSC generated as described above. Cocultures of BCP on BMSC were performed at 37°C and 5% C02, in Opti-MEM medium (GIBCO) supplemented with 10% vol/vol heat-inactivated FCS, IO mmol/L HEPES, 2 mmol/L glutamine, 5 X I 0-5 mol/L 2-0-mercaptoethanol, penicillin ( I 00 U/mL) and streptomycin ( 100 pg/mL), further refered to as complete Opti-MEM medium.
Cocultures ofCD34+ cells on BMSC were performed in complete RPMI 1640 medium consisting of RPMI 1640 (GIBCO) supplemented with 10% vol/vol heat-inactivated
mol/L 2-0-mercaptoethanol, penicillin (100 U/mL), and streptomycin (100 pg/mL).
CDlO+sp-BCP and CD34' cells were also seeded on confluent layers of BMSC, skin fibroblasts obtained after 10 to 20 passages of skin biopsies from normal adult donors, synoviocytes obtained after 2 to 8 passages of human synovial biopsies from rheumatoid arthritis patients, SV-40-transformed human BMSC (Pinkney and Dalcourt cell lines; kindly provided by Dr Jack Singer, University of Washington, Seattle, WA), or MRC5 human lung fibroblastic line (American Type Culture Collection, Rockville, MD). In some experiments, the adherent cells were irradiated (5,000 rad) at confluence.
Recombinant human IL-7 (2.5 X lo6 U/mg; R & D Systems, Minneapolis, MN) was used at 10 ng/mL in a series of BCP cultures. Also, some cultures of hematopoietic cells were supplemented with either 5 pg/mL of a purified rat antihuman IL-7-neutralizing MoAb (BVIO-40F6; kindly provided by Dr John Abrams, DNAX, Palo Alto, CA), or with 5 pg/mL of an isotype-matched rat MoAb of unrelated specificity.
After 7 days of incubation, cultures were pulsed with 1 pCi methyl 'H-thymidine (3H-TdR; CEA, Saclay, France; specific activity, 25 Ci/mmol) during 8 hours, and were subsequently harvested. Radioactivity was measured in a 0-scintillation counter, and results were expressed as mean counts per minute of triplicate wells f standard deviation (cpm f SD).
Long-Term Cultures of CD34+ Cells on BMSC
Long-term myeloid cultures were established by seeding 5 X IO4 adult BM CD34+ cells onto confluent BMSC in 35-mm tissue culture grade Petri plates (Corning, Corning, NY). Cultures were performed in complete aMEM medium and incubated at 3 7 T , 5% C02, in a fully humidified atmosphere. Every week, half of the medium was changed particular care was taken not to remove nonadherent cells. At regular intervals, cultures were killed for cell counts and phenotypic analysis. Thus, numbers of hematopoietic cells were evaluated by counting trypan-blue negative cells (in adherent and nonadherent fractions) using a hemocytometer. BMSC were excluded from the counts because of their large size. In parallel, the BMSC-nonadherent cells recovered from the cultures were characterized with the following MoAbs: HPCA-I (CD34), CALLA-FITC (CD IO), Leu-M3-FITC (CD 14), Leu-M I (CD 15), Leu-M9 (CD33), and HLe-1-FITC (CD45; Becton Dickinson, Mountain View, CA); and IOB4 (CD19) and IOT3 (CD3; Immunotech), as described above.
RESULTS
Characterization of BMSC in Culture
Microscopic observation of cultures of adherent BM cells depleted of hematopoietic elements (see Materials and Methods), showed a homogeneous network of interdigitated SC forming a syncitial meshwork where cells were difficult to individualize (Fig IA) . The phenotype of the BMSC in culture was analyzed by microscopic examination after in situ staining of cytoskeletal and extracellular matrix components and by flow cytometry analysis of surfacemembrane molecules after detachment of the cells from the culture vessel. The results obtained are summarized in Table l .
The BMSC were found to represent connective-tissue forming cells, as indicated by the expression of cytoskeletal vimentin, and a number of extracellular matrix components such as laminin, fibronectin, and collagens (I, 111, and IV). In addition, the BMSC expressed both the cell-surface molecule recognized by 6-19 antibody3* and the CDlO marker (Table I and Fig 2) , and uniformly displayed asmooth muscle (a-SM) actin stress fibers (Fig 1B) . In contrast, the antigen recognized by STRO-I antibody33 was not detected, and the BMSC lacked CD34 expression (Fig 2) .
Several cell-surface membrane adhesion receptors could be found on the BMSC (Table 1 and Fig 2) . These included the PI integrins VLA-1 and VLA-5, the hyaluronate receptor CD44, and a member of the Ig superfamily, VCAM-1.
The SC lacked CD45 (Fig 2) , consistent with the fact that cells of hematopoietic origin had been depleted from the cultures. In line with this finding, no macrophages (CD14' cells) could be observed in the BMSC cultures (Fig 2) . Finally, no cytoplasmic von Willebrand factor (vWF) was detected in the cultures (Table l 
BMSC Support the Proliferation of Both Early Myeloid and B-Lymphoid Cells
The functional capacity of BMSC to induce the proliferation of different hematopoietic cell populations was investigated. Thus, purified CD34+ cells or CDIO+sp-BCP were added to confluent BMSC, and cocultures were subsequently analyzed. A fraction of the CD34' cells and the BCP rapidly adhered to the BMSC after culture inception.
As shown in Table 2 the BMSC incorporated only low levels of 3H-TdR (Table  2) . Consistent with this conclusion, comparable levels of 'H-TdR incorporation were observed when hematopoietic cells were cultured in the presence of irradiated (5.000 rad) BMSC.
In parallel to the enhanced 'H-TdR uptake. a considerable increase in cell numbers was observed in cultures of CD34' progenitors on BMSC. Thus. in a representative experiment, shown in Fig 3A, the input CD34' cells rapidly expanded more than 10-fold in the presence of BMSC. Typical "cobblestone" areas were observed after 3 weeks of coculture of BM CD34' cells with BMSC, suggesting longerterm hematopoiesis. Indeed, cells of hematopoietic origin could still be recovered after 9 weeks of culture (Fig 3A) . Furthermore, the cocultures were found to include clonogenic cells that gave rise to myeloid colonies in semisolid medium for up to 7 weeks. However, we were able to detect colony-forming cells for up to 12 weeks in Dexter-type cultures of total BM (data not shown).
Phenotypic analysis showed the myeloid affiliation of the cells recovered from BMSC-dependent cultures of CD34' cells. as judged by expression of CD14 and CDI 5 antigens and lack ofCDI9 and CD3 lymphoid antigens (Fig 3B) . In addition. a maturation sequence occurred within the myeloid lineage because the CD34 marker was lost on the BMSC-nonadherent cells on culture. concommitant with acquisition of CD 14 and CDI 5 which are absent on freshly isolated CD34' cell^.^' Finally, in line with the presently described 'H-TdR data (Table 2) , we have previously shown that cell numbers can be expanded to fourfold on coculture of fetal CDIO'sp-BCP with BMSC and that the cells recovered display a BCP phenotype (CD IO', CD I9+, and ~l g -) .~ Taken together. these data show that native human myofibroblastic BMSC induce the proliferation of both early myeloid-and R-lymphoid-lineage cells.
BCP Prolij?ratioti is Sdectiwlr Indrrced by BMSC
The ability of BMSC to induce short-term proliferation of early myeloid and B-lymphoid cells was compared with that of several other human fibroblast-like cells. Thus, CDIO'sp-BCP or CD34' cord blood cells were plated onto various confluent adherent cell layers (see Materials and Methods). As shown in Fig 4 , the BCP were found to incorporate considerably higher 'H-TdR levels when cultured on BMSC, as compared with skin fibroblasts or synoviocytes. In addition, neither the SV-40-transformed cells tested nor the MRCS cell line induced significant 'H-TdR uptake by the BCP. In contrast to these observations, high levels of 'H-TdR uptake could be induced in CD34+ cord blood cells by coculture with skin fibroblasts, synoviocytes, and SV-40-transformed SC, in addition to the BMSC. Taken together, these results indicate that myofibroblastic BMSC have a selective advantage for induction of BCP proliferation, as compared with a number of other fibroblast-like cells tested.
Role of IL-7 in BCP Proliferation in the Presence of Adherent Cells
The reasons underlying the selective potential ofthe myofibroblastic BMSC for induction of BCP proliferation were explored. Because IL-7 is a stromal-derived factor that plays a central role in B lymphopoiesis, the effect of a neutralizing anti-IL-7 antibody was evaluated on BMSC-dependent BCP proliferation. As shown in Fig 5, the addition of 5 pg/mL of anti-IL-7 MoAb strongly inhibited (by 6 1 % in the experiment presented) 3H-TdR uptake by CD 1 O+sp-BCP on confluent BMSC, as compared with an isotype-matched, unrelated control antibody at the same concentration. In contrast, the anti-IL-7 antibody had no significant effect in cultures of cord blood CD34' cells on BMSC (Fig 5) . important role in the ability of BMSC to induce the proliferation of BCP but does not in that of myeloid progenitors.
Thus, we investigated whether adherent cells that poorly supported BCP proliferation would acquire this capacity in the presence of exogenously supplied IL-7. Indeed, as shown in Table 3 , addition of 10 ng/mL IL-7 to cultures containing skin fibroblasts and synoviocytes resulted in markedly higher proliferation of CD 1 O+sp-BCP, as compared with cultures performed in the absence of exogenous IL-7. However, addition of IL-7 to SV-40-transformed or MRC5 cells did not result in significant induction of BCP proliferation. This failure to induce BCP proliferation in the presence of IL-7 was observed after irradiation of the adherent cells (5,000 rad), excluding that the lack of effect represents medium exhaustion.
Collectively, these data indicate that IL-7 production is an important parameter, but other factors also influence the capacity of fibroblast-like cells to support the proliferation of BCP.
DISCUSSION
We have previously reported a modification of human long-term BM cultures that permits the enrichment of native fibroblastic SC at the expense of hematopoietic cells within the adherent layer, based on the selective advantage of SC to adhere to plastic.23 Herein, we describe in detail a second step for the isolation of SC from human BM by depleting cells bearing hematopoietic markers. Thus, BMSC cultures were generated that induced short-term proliferation of both early myeloid and B-lymphoid cells. The BMSC lacked detectable macrophages as judged by absence of staining with anti-CD14, negative polymerase chain reaction (PCR) analysis for CD 14 mRNA (data not shown), and absence of CD45, a marker of cells of hematopoietic derivation. These results show that macrophages, which represent the most conspicuous hematopoietic population in human BM adherent layers, are not necessary to trigger the proliferation of early myeloid or B-lymphoid cells. Furthermore, the BMSC did not display vWF, likewise indicating that endothelial elements are not a requirement for proliferation of these hematopoietic cells.
In addition to induction of short-term proliferation of CD34+ cells, the BMSC allowed the expansion and maintenance of myeloid cells for at least 9 weeks. However, the present conditions do not appear optimal for long-term CDl (kslgM-CD.W+ cells cells myelopoiesis, as granulocyte-macrophage colony-forming cells (GM-CFC) were not detected beyond 7 weeks, whereas cultures established from total BM are known to maintain production of such clonogenic cells for 12 weeks or m~re.".~.'~ Thus, accessory cells other than the presently isolated BMSC are likely important for long-term GM-CFC production. In this context, macrophages are a major source of IL-1 and tumor necrosis factor (TNF). factors that greatly upregulate the production of a number of cytokines by BMSC.3S'37 IL-1 and TNF have also been shown to modify extracellular matrix synthesis by SC. 37 In addition to macrophages, endothelial cells may also play a role in long-term BM cultures, as suggested by murine st~dies.~'.'~ Further illustrating the complex interplay which regulates hematopoietic development, murine SC are known to shift from a B-lymphopoietic to myelopoietic environment as a consequence of IL-I stimuIation.4' Thus, it should be kept in mind that stromal elementsand other accessory cells form a complex architectural network within the BM, implying that multiple interactions between these cell types are likely to play a regulatory role both in early myeloid and B-lymphoid development. We have previously shown that CD34' cells isolated from adult BM, but not from cord blood, contain a significant proportion of early BCP which express CD19 and CDlO antigens." Yet, CD34' BM cells developed exclusively along the myeloid pathway on culture with BMSC, with no detectable persistance of B-lineage cells. These data raise the possibility that the myeloid progenitors may negatively interfere with BCP development.
Because both early myeloid and B-lymphoid lineage cells could be induced to proliferate on BMSC, it appeared of particular interest to characterize this SC population with respect to its affiliation and phenotypic diversity. Thus. the BMSC were found to display the 6-19 molecule and the CD IO metallopeptidase, two cell-surface markers previously described on SC in long-term BM culture^.^^^^' In line with this finding, the BMSC expressed type-IV collagen and. furthermore, displayed vimentin and a-SM actin known to be cytoskeleton constituents of myofibroblastic BMSC.2s.42.43 The uniform expression of a-SM actin indicates that the BMSC represent a well-differentiated cell p o p ulation. In line with this notion, the BMSC expressed neither CD34, found on fibroblastic precursorsu nor In the mouse, a number of BMSC lines supporting the growth of hematopoietic progenitors have been established by successive subcultures. Such SC display either a fibroblastic, endothelial, or fibroendothelial phen~type.'~ Some of the stromal lines induce myelopoiesis as well as B lymp h o p o i e s i~,~~,~~ whereas others appear restricted to support one or the other lineage.I4 In addition, some clones act on different stages of B-cell ontogeny, suggesting a maturation stage stroma-specificity for early B-lineage ~e l l s .~~,~* Further studies will be required at the clonal level to address whether inherent functional heterogeneity exists within the human myofibroblastic SC population described in the present study.
The BMSC were found not to be specific in their capacity Finally, in contrast to the situation observed with myeloid cells, the BMSC were found to be far superior to a number of fibroblastic-like cell types tested with respect to their support of BCP proliferation. Because BMSC-dependent BCP proliferation is largely mediated by endogenously produced IL-7, as shown by an inhibitory effect of anti-IL-7 antibody, it appears likely that BMSC differ from the other adherent cells analyzed, in part by their ability to produce IL-7. This notion is supported by our observation that the capacity of synoviocytes or skin fibroblasts to induce BCP proliferation could be considerably enhanced through the addition of exogenous IL-7. However, we presently cannot conclude as to whether the observed differences are inherent or reflect culture conditions such as the number of passages of the adherent cells before coculture with BCP. This issue appears to be complicated by low IL-7 production levels. Thus, IL-7 mRNA was evidenced in the BMSC by PCR, but not by Northern blot analysis (data not shown).
IL-7 induced only low levels of BCP proliferation in the absence of accessory cells, in contrast to its effect in the presence of fibroblastic-like layers. These results show a synergy between IL-7 and at least another growth signal'which appears widely distributed. Of interest, we furthermore observed that anti-IL-7 antibody did not completely inhibit BMSC-associated BCP proliferation, which remained higher than in the presence of the nonsupplemented other fibroblastic-like cells tested. These data suggest that some of the BCP may proliferate independently of IL-7, in response to an activity selectively produced by the BMSC.
Taken together, the present study shows that myofibroblastic human BMSC cultures devoid of accessory cells of hematopoietic affiliation can induce the proliferation of both early myeloid and B-lymphoid cells. Such a physiologic model should permit to address the precise contribution of native myofibroblasts to the development of the different hematopoietic lineages within the BM. For personal use only. on October 26, 2017 . by guest www.bloodjournal.org From
